Insider Transactions in Q4 2022 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
605
+0.08%
|
$7,260
$12.18 P/Share
|
|
Dec 31
2022
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
605
+0.63%
|
$7,260
$12.18 P/Share
|
|
Dec 31
2022
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
645
+1.02%
|
$7,740
$12.18 P/Share
|
|
Dec 15
2022
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,916
-2.97%
|
$61,236
$21.5 P/Share
|
|
Dec 15
2022
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,557
-2.45%
|
$32,697
$21.5 P/Share
|
|
Oct 13
2022
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49,274
-6.43%
|
$1,281,124
$26.97 P/Share
|